Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex

Ylva Bonde, Torsten Plösch, Folkert Kuipers, Bo Angelin, Mats Rudling – 24 July 2012 – Secretion of cholesterol into bile is important for the elimination of cholesterol from the body. Thyroid hormone (TH) increases biliary cholesterol secretion and hepatic gene expression of adenosine triphosphate (ATP)‐binding cassette, subfamily G (WHITE), member 5 (ABCG5) and ATP‐binding cassette, subfamily G (WHITE), member 8 (ABCG8), two half‐transporters that act as a heterodimeric complex promoting sterol secretion.

Influence of kinship on donors' mental burden in living donor liver transplantation

Yesim Erim, Mingo Beckmann, Sylvia Kroencke, Georgios C. Sotiropoulos, Andreas Paul, Wolfgang Senf, Karl‐Heinz Schulz – 24 July 2012 – In the context of living donor liver transplantation (LDLT), German transplantation law stipulates that donor candidates should primarily be relatives of the recipients or persons with distinct and close relationships. In this study, we investigated the influence of the relationship between the donor and the recipient on the donor's emotional strain before transplantation.

RhoE is frequently down‐regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho‐Kinase/Myosin phosphatase target pathway

Wei Ma, Carmen Chak‐Lui Wong, Edmund Kwok‐Kwan Tung, Chun Ming Wong, Irene Oi‐Lin Ng – 24 July 2012 – Deregulation of Rho guanosine triphosphatase (GTPase) pathways plays an important role in tumorigenesis and metastasis of hepatocellular carcinoma (HCC). RhoE/Rnd3 belongs to an atypical subfamily of the RhoGTPase, the Rnd family, as it lacks the intrinsic GTPase activity and remains always in its active GTP‐bound form. In this study we investigated the role of RhoE in HCC.

Human liver stem cells improve liver injury in a model of fulminant liver failure

Maria Beatriz Herrera, Valentina Fonsato, Stefania Bruno, Cristina Grange, Nicholas Gilbo, Renato Romagnoli, Ciro Tetta, Giovanni Camussi – 24 July 2012 – Liver transplantation is currently the only effective therapy for fulminant liver failure, but its use is limited by the scarcity of organs for transplantation, high costs, and lifelong immunosuppression. Here we investigated whether human liver stem cells (HLSCs) protect from death in a lethal model of fulminant liver failure induced by intraperitoneal injection of D‐galactosamine and lipopolysaccharide in SCID mice.

Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4

David Ellinghaus, Trine Folseraas, Kristian Holm, Eva Ellinghaus, Espen Melum, Tobias Balschun, Jon K. Laerdahl, Alexey Shiryaev, Daniel N. Gotthardt, Tobias J. Weismüller, Christoph Schramm, Michael Wittig, Annika Bergquist, Einar Björnsson, Hanns‐Ulrich Marschall, Morten Vatn, Andreas Teufel, Christian Rust, Christian Gieger, H‐Erich Wichmann, Heiko Runz, Martina Sterneck, Christian Rupp, Felix Braun, Rinse K. Weersma, Cisca Wijmenga, Cyriel Y. Ponsioen, Christopher G. Mathew, Paul Rutgeerts, Séverine Vermeire, Erik Schrumpf, Johannes R. Hov, Michael P. Manns, Kirsten M.

High‐mobility group box 1 (HMGB1)‐toll‐like receptor (TLR)4‐interleukin (IL)‐23‐IL‐17A axis in drug‐induced damage‐associated lethal hepatitis: Interaction of γδ T cells with macrophages

Xuefu Wang, Rui Sun, Haiming Wei, Zhigang Tian – 23 July 2012 – Acetaminophen overdose causes acute liver inflammation with neutrophil infiltration; however, the mechanism of damage‐associated inflammation has not been elucidated. In this study we found that the HMGB1‐TLR4‐IL‐23‐IL‐17A axis played a crucial role in acetaminophen‐induced infiltration of neutrophils and liver injury. Notably, interleukin (IL)‐17A and IL‐23 significantly increased after acetaminophen challenge.

Estrogen‐sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3

Jiajie Hou, Juan Xu, Runqiu Jiang, Youjing Wang, Chen Chen, Lei Deng, Xingxu Huang, Xuehao Wang, Beicheng Sun – 23 July 2012 – Protein tyrosine phosphatase receptor type O (PTPRO), one of the receptor types of phosphotyrosine phosphatases (PTP), was recently described as a tumor suppressor in various kinds of cancers. We aimed to clarify the role of PTPRO in hepatocellular carcinoma (HCC).

Subscribe to